Cytogenetic and myelodysplastic alterations after autologous hemopoietic stem cell transplantation

Leukemia Research

Volumn 23, Issue 3, 1999, Pages 291-297

  Lambertenghi Deliliers, Giorgio ^a   Annaloro, Claudio ^a   Pozzoli, Ermanno ^a   Oriani, Alessandro ^a   Della Volpe, Aldo ^a   Soligo, Davide ^a   Lambertenghi Deliliers, Daniela ^a   Tagliaferri, Elena ^a   Bertolli, Vanda ^a   Romitti, Lorenza ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Servizio di Citogenetica   (Italy)

Author keywords

Autologous transplantation; Bone marrow biopsy; Cytogenetics; Secondary myelodysplasia

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW BIOPSY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHROMOSOME ABERRATIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; TRANSPLANTATION, AUTOLOGOUS;

EID: 0345130044     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00139-8     Document Type: Article

References (30)

1. Witherspoon R.P., Fisher L.D., Schoch G.et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. New Engl J Med. 312:1989;784.
2. Bhatia S., Ramsay N.K.C., Steinbuch M.et al. Malignant neoplasms following bone marrow transplantation. Blood. 87:1996;3633.
3. Deeg H.J., Socié G., Schoch G.et al. Malignancies after bone marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 87:1996;386.
4. Rohatiner A. Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation. J Clin Oncol. 12:1994;2521.
5. Darrington D.L., Vose J.M., Anderson J.R.et al. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol. 12:1994;2527.
6. Stone R.M., Neuberg D., Soiffer R.et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol. 12:1994;2535.
7. Miller J.S., Arthur D.C., Litz C.E., Neglia J.P., Miller W.J., Weisdorf D.J. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood. 83:1994;3780.
8. Traweek S.T., Slovak M.L., Nademanee A.P., Brynes R.K., Niland J.C., Forman S.J. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood. 84:1994;957.
9. Stone R.M. Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress. Blood. 83:1994;3437.
10. Incidenza dei tumori e cause di morte in Lombardia. Regione Lombardia (Settore Sanità e Igiene). Milano, 1986.
11. Lambertenghi Deliliers G., Annaloro C., Oriani A.et al. Idarubicin in the therapy of acute myeloid leukemia: final analysis in 57 previously untreated patients. Semin Oncol. 20(Suppl 8):1993;27.
12. Bassan R., Battista R., Corneo G.et al. Idarubicin in the initial treatment of adults with acute lymphoblastic leukemia: the effect of drug schedule on outcome. Leuk Lymph. 11:1993;105.
13. Philip T., Guglielmi C., Hagenbeek A.et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New Engl J Med. 333:1995;1540.
14. Wheleer C., Antin J.H., Churchill W.H.et al. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study. J Clin Oncol. 8:1990;648.
15. Cassileth P.A., Anderson J., Lazarus H.M.et al. Autologous bone marrow transplantation in acute myeloid leukemia in first remission. J Clin Oncol. 11:1993;314.
16. Bierman P.J., Bagin R.G., Jagannath S.et al. High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long term follow-up in 128 patients. Ann Oncol. 4:1993;767.
17. Perot C., van den Akker J., Laporte J.P.et al. Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide. Leukemia. 7:1993;509.
18. Baker M.C., Lawler S.D., Harris H., Barrett A., Powlest R.L. Radiation damage in patients treated by total-body irradiation, bone marrow grafting, and cyclosporin. Radiat Res. 105:1986;413.
19. De Vore R., Whitlock J., Hainsworth J.D., Johnson D.H. Therapy-related acute nonlymphocytic leukemia with monocytic features and rearrangement of chromosome 11q. Ann Int Med. 110:1989;740.
20. Orazi A., Cattoretti G., Soligo D., Luksch R., Lambertenghi Deliliers G. Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment. Leukemia. 7:1993;838.
21. Lambertenghi Deliliers G., Orazi A., Luksch R., Annaloro C., Soligo D. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol. 78:1991;161.
22. Deeg H.J., Whiterspoon R.P. Risk factors for the development of secondary malignancies after marrow transplantation. Hematol Oncol Clin North Am. 7:1993;417.
23. Chan T., Juneja S., Wolf M., Januszewicz E., Cooper I. Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases. Bone Marrow Transplant. 13:1994;145.
24. Gale R.E., Bunch C., Moir D.J., Patterson K.G., Goldstone A.H., Linch D.C. Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patterns. Br J Haematol. 93:1996;53.
25. Hatfill S.J., La Cock C.J.R., Laubscher R., Downing T.G., Kirby R. A role for mitochondrial DNA in the pathogenesis of radiation-induced myelodysplasia and secondary leukemia. Leuk Res. 17:1993;907.
26. Liang J.C., Bailey N.M., Gabriel G.J.et al. A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity. Leuk Lymph. 9:1993;503.
27. Bartlett N.L., Rosenberg S.A., Hoppe R.T., Hancock S.L., Horning S.J. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report. J Clin Oncol. 13:1995;1080.
28. Nademanee A., O'Donnell M.R., Snyder D.S.et al. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors. Blood. 85:1995;1381.
29. Colwill R., Crump M., Couture F.et al. Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. J Clin Oncol. 13:1995;396.
30. Chopra R., McMillan A.K., Linch D.C.et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center 8-year study of 155 patients. Blood. 81:1993;1137.